Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

There are currently, however, two radioligands that are United States Food and Drug Administration (FDA)-approved for the treatment of mCRPC patients: Patients with advanced prostate cancer are at ...

Professor Adrian Crellin, 70, noticed blood in his urine and promptly sought medical attention from his GP, leading to a ...

Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.

A top UK doctor has been left ‘devastated’ after being diagnosed with an incurable cancer he’s spent his life treating.

More men are getting checked for prostate cancer and realising they have the disease at an early stage, but charity Prostate ...

Two metastatic lesions in the middle section ... that are used to diagnose prostate cancer. Source: Prostate Cancer UK A follow-up bone scan identified a tumour in the man's right shinbone ...

Since the initial diagnosis, Prof Crellin has undergone chemotherapy and radiotherapy and continues to receive hormone ...

Cancer a life-threatening disease can spread or metastasise from its original location to other parts of the body The lungs are a frequent site of metastasis An oncologist explains why ...